Most breast cancers are hormone-dependent, and as such, classification is commonly based on expression of the following hormone receptors: estrogen (ER), progesterone (PR), human epidermal growth factors (HER2), or none, termed “triple-negative breast cancer” [74]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.